Explore
Search results
Since 2014, Aspen Ideas: Health has welcomed over 700 inspiring women leaders to our stages to share their bold approaches to better health. In honor of Women's History Month, we're taking a look back at some of the many highlights. From medical researchers and clinicians to entrepreneurs and activists, meet 12 change makers who are breaking barriers to reimagine a healthi...
Aspen Ideas: Health is where the arts meet health. Ahead of the 10th annual event this summer, we're looking back at some of the innovative artists, musicians, actors, filmmakers, playwrights, and dancers who have shared their creative expressions of the mind, body, and spirit on our stages. Explore how the arts help expand our understanding of health and well-being.
Hospitals and health systems have a critical role to play in turning health equity talk into action. Learn how the field is using strategic investments to drive innovative solutions forward. Presented by the American Hospital Association.
Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the world- from infectious diseases like malaria and HIV to non-infectious health needs like prenatal care. Learn how Abbott is intentionally approaching product development to democratize, decentralize and...
As new public health threats brew, we need to ensure there is capacity within our health systems to serve the people of this country. There is a strong business case for readiness, but it requires a paradigm shift in how we think about the intersection of routine care, unscheduled care, and the health of the populations we serve.
Women's History Month is an opportunity to honor the indelible contributions women have made in societies around the world. But don't wait until remarkable women are in history books to celebrate them! Learn about contemporary women making their mark on the world.
What would happen if genetic sequencing were standard care for undiagnosed diseases? And how can we ensure that the future of genomics benefits everyone, not just the one percent?